CY1107866T1 - Ενας φορεας εκφρασης μαγιας και μια μεθοδος παρασκευης μιας ανασυνδυαζομενης πρωτεϊνης με εκφραση σε ενα κυτταρο μαγιας - Google Patents

Ενας φορεας εκφρασης μαγιας και μια μεθοδος παρασκευης μιας ανασυνδυαζομενης πρωτεϊνης με εκφραση σε ενα κυτταρο μαγιας

Info

Publication number
CY1107866T1
CY1107866T1 CY20081100089T CY081100089T CY1107866T1 CY 1107866 T1 CY1107866 T1 CY 1107866T1 CY 20081100089 T CY20081100089 T CY 20081100089T CY 081100089 T CY081100089 T CY 081100089T CY 1107866 T1 CY1107866 T1 CY 1107866T1
Authority
CY
Cyprus
Prior art keywords
expression
yeast
preparation
recombinant protein
expression vector
Prior art date
Application number
CY20081100089T
Other languages
Greek (el)
English (en)
Inventor
Désiré José Collen
Nubuo Nagai
Yves Laroche
Original Assignee
Thrombogenics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031196A external-priority patent/GB0031196D0/en
Priority claimed from GB0116690A external-priority patent/GB0116690D0/en
Priority claimed from GB0116702A external-priority patent/GB0116702D0/en
Application filed by Thrombogenics N.V. filed Critical Thrombogenics N.V.
Publication of CY1107866T1 publication Critical patent/CY1107866T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CY20081100089T 2000-12-21 2008-01-25 Ενας φορεας εκφρασης μαγιας και μια μεθοδος παρασκευης μιας ανασυνδυαζομενης πρωτεϊνης με εκφραση σε ενα κυτταρο μαγιας CY1107866T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0031196A GB0031196D0 (en) 2000-12-21 2000-12-21 Recombinant human plasminogen and plasmin: methods for high yield production stabilization and use for treatment
GB0116690A GB0116690D0 (en) 2001-07-09 2001-07-09 Human plasminogen and plasmin
GB0116702A GB0116702D0 (en) 2001-07-09 2001-07-09 Human plasminogen and plasmin
EP01271444A EP1343903B1 (en) 2000-12-21 2001-12-20 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell

Publications (1)

Publication Number Publication Date
CY1107866T1 true CY1107866T1 (el) 2013-06-19

Family

ID=27256020

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100089T CY1107866T1 (el) 2000-12-21 2008-01-25 Ενας φορεας εκφρασης μαγιας και μια μεθοδος παρασκευης μιας ανασυνδυαζομενης πρωτεϊνης με εκφραση σε ενα κυτταρο μαγιας

Country Status (11)

Country Link
US (1) US7445775B2 (https=)
EP (1) EP1343903B1 (https=)
JP (2) JP4047170B2 (https=)
AT (1) ATE378413T1 (https=)
AU (1) AU2002218890A1 (https=)
CY (1) CY1107866T1 (https=)
DE (1) DE60131450T2 (https=)
DK (1) DK1343903T3 (https=)
ES (1) ES2296705T3 (https=)
PT (1) PT1343903E (https=)
WO (1) WO2002050290A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998121B2 (en) * 2003-01-23 2006-02-14 Milkhaus Laboratory, Inc. Method of treatment of connective tissue disorders by administration of streptolysin O
DE10390418D2 (de) * 2002-02-06 2005-01-13 N Zyme Biotec Gmbh Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
AU2003210137A1 (en) * 2002-02-06 2003-09-02 N-Zyme Biotec Gmbh Method for producing recombinant proteins in micro-organisms
GB0228409D0 (en) 2002-12-06 2003-01-08 Thromb X Nv Pharmacological vitreolysis
KR100595864B1 (ko) * 2004-01-27 2006-06-30 재단법인 목암생명공학연구소 형질전환 사카로마이세스 세레비지애 균주 및 이를 이용한ｌｋ8 단백질의 생산방법
CN1938427A (zh) 2004-02-11 2007-03-28 比奥莱克斯公司 纤溶酶原和微纤溶酶原在浮萍中的表达
CN102660564B (zh) * 2004-04-22 2013-05-08 泰勒克里斯生物治疗学公司 重组修饰的纤溶酶
CN100368524C (zh) * 2005-05-17 2008-02-13 上海大学 巴士德毕赤酵母gs115/pfk-k5的高密度发酵方法
US20070134231A1 (en) * 2005-12-13 2007-06-14 Jani Dharmendra M Method for prolonging activity of autodegradable enzymes and compositions thereof
US20070134230A1 (en) * 2005-12-13 2007-06-14 Jani Dharmendra M Method for prolonging activity of autodegradable enzymes
US20070196350A1 (en) * 2006-02-22 2007-08-23 Bartels Stephen P Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment
US20070212358A1 (en) * 2006-03-10 2007-09-13 Bartels Stephen P Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment
PL2220221T3 (pl) * 2007-11-29 2015-07-31 Grifols Therapeutics Inc Rekombinacyjnie zmodyfikowana plazmina
WO2009104199A1 (en) * 2008-02-19 2009-08-27 Biocon Limited A method of obtaining purified heterologous insulins expressed in yeast
MX2010013282A (es) 2008-06-04 2010-12-21 Talecris Biotherapeutics Inc Composicion, metodo y kit para la preparacion de plasmina.
HUE025670T2 (en) 2009-03-03 2016-04-28 Grifols Therapeutics Inc A method for producing plasminogen
WO2011004011A1 (en) 2009-07-10 2011-01-13 Thrombogenics Nv Variants of plasminogen and plasmin
ES2534911T3 (es) 2009-08-28 2015-04-30 Thrombogenics N.V. Uso de plasmina para el tratamiento de fallo de filtración después de trabeculectomía
JP6085568B2 (ja) 2011-01-05 2017-02-22 スロンボジェニックス・ナムローゼ・フェンノートシャップＴｈｒｏｍｂｏＧｅｎｉｃｓ ＮＶ プラスミノーゲンおよびプラスミンの変異体
US9644196B2 (en) 2011-08-12 2017-05-09 Thrombogenics Nv Plasminogen and plasmin variants
CN110066783B (zh) * 2019-05-16 2021-07-13 重庆派金生物科技有限公司 一种无自切形式的微纤溶酶制备方法
CN113355309B (zh) * 2021-08-10 2021-11-05 迈威(上海)生物科技股份有限公司 重组截短型人纤维蛋白溶酶制备工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774087A (en) * 1987-08-14 1988-09-27 Northwestern University Micro-size fibrinolytic plasmin
WO1990013640A1 (en) 1989-05-01 1990-11-15 The University Of Notre Dame Du Lac Methods and materials for expression of human plasminogen in a eukaryotic cell system
GB9222758D0 (en) * 1992-10-29 1992-12-09 British Bio Technology Proteins and nucleic acids
US5288489A (en) 1991-08-28 1994-02-22 Orion Therapeutic Systems, Inc. Fibrinolysis and fibrinogenolysis treatment
ATE349226T1 (de) * 1998-09-29 2007-01-15 Leuven Res & Dev Vzw Verwendung von verbindungen die alpha2- antiplasmin in vivo reduzieren zur herstellung einer zusammensetzung zur behandlung ischämischer schlaganfälle

Also Published As

Publication number Publication date
AU2002218890A1 (en) 2002-07-01
JP4047170B2 (ja) 2008-02-13
DE60131450D1 (de) 2007-12-27
ES2296705T3 (es) 2008-05-01
JP4250660B2 (ja) 2009-04-08
US7445775B2 (en) 2008-11-04
EP1343903A1 (en) 2003-09-17
EP1343903B1 (en) 2007-11-14
PT1343903E (pt) 2008-02-18
JP2004526427A (ja) 2004-09-02
DK1343903T3 (da) 2008-03-10
US20040071676A1 (en) 2004-04-15
DE60131450T2 (de) 2008-10-16
WO2002050290A1 (en) 2002-06-27
ATE378413T1 (de) 2007-11-15
JP2007195558A (ja) 2007-08-09

Similar Documents

Publication Publication Date Title
CY1107866T1 (el) Ενας φορεας εκφρασης μαγιας και μια μεθοδος παρασκευης μιας ανασυνδυαζομενης πρωτεϊνης με εκφραση σε ενα κυτταρο μαγιας
ES2042693T5 (es) Formulaciones de proteinas plasmaticas y recombinantes en medios de baja potencia ionica.
DE602004011770D1 (de) Fusionsproteine
ATE316982T1 (de) Mehrere zytokin-antikörper komplexen
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
DE60139311D1 (de) Dendritzell-spezifische kostimulierende moleküle
ATE407697T1 (de) Erythropoietin immunglobulin fusionsproteine
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
DK1140173T4 (da) Vaskulære endothelcellevækstfaktorantagonister og anvendelser deraf
CY1114526T1 (el) Κατασταλτικες πρωτεϊνες μιας πρωτεασης (protease) και χρησεις αυτων
EA200401504A1 (ru) Слитый белок из числа регуляторных/вспомогательных белков вич
ATE370159T1 (de) Streptavidin-bindungspeptid
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
FR2857267B1 (fr) Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
DE60039049D1 (de) Erhöhte expression von proteinen mittels gfp
ATE448793T1 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
IT1271486B (it) Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
DK0456698T3 (da) Hidtil ukendte ekspressionsvektorer og fremgangsmåder til intracellulær proteinekspression
ATE417105T1 (de) Spleissvariante des kopftrauma induzierten zytoplasmatischen calcium-bindenden proteins
ECSP993285A (es) Sintesis recombinante de beta lipotropina y otros peptidos
PE20001400A1 (es) Inmunotoxinas anti-cd3 y usos terapeuticos para las mismas